Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

LMAT stock hub

LeMaitre Vascular, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LMATis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.5B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

LMAT

In the news

Latest news · LMAT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E35.1

P25 12.3P50 18.4P75 33.1

Trailing P/E39.7

P25 14.9P50 23.2P75 38.5

ROE16.5

P25 -105.6P50 -46.5P75 -3.1

ROIC23.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LMAT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

273

Groups with data

Currency

USD

Showing 273 of 273 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001158895
Company name	LeMaitre Vascular, Inc.
Country	United States
Country code	US
Cusip	525558201
Employees	655
Employees Change	-9%
Employees Change Percent	-1.36
Enterprise value	$2.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
IPO Date	2006-10-19
Isin	US5255582018
Last refreshed	2026-05-10
Market cap	$2.5B
Market cap category	Mid-Cap
Price	$108
Price currency	USD
Rev Per Employee	391,270.23x
Sector	Healthcare
Sic	3841
Symbol	LMAT
Website	https://www.lemaitre.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.53%
EV Earnings	36.68x
EV Sales Forward	7.88x
EV/EBIT	33.53x
EV/EBITDA	29.07x
EV/FCF	28.93x
EV/Sales	8.93x
FCF yield	3.21%
Forward P/E	35.09x
P/B ratio	6.07x
P/E ratio	39.69x
P/S ratio	9.62x
PE Ratio10 Y	39.9x
PE Ratio3 Y	43.87x
PE Ratio5 Y	44.6x
PEG ratio	1.75x
PS Forward	8.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.64%
EBITDA Margin	30.73%
FCF margin	30.87%
Gross margin	71.33%
Gross Profit	$182.8M
Gross Profit Growth	17.45%
Gross Profit Growth Q	16.84%
Gross Profit Growth3 Y	18.52%
Gross Profit Growth5 Y	15.76%
Net Income	$62.4M
Net Income Growth	38.17%
Net Income Growth Q	42.39%
Net Income Growth Quarters	13%
Net Income Growth Years	3%
Net Income Growth3 Y	44.6%
Net Income Growth5 Y	21.08%
Pretax Margin	31.46%
Profit Margin	24.35%
Profit Per Employee	$95,270
Profitable Years	17
ROA	7.2
Roa5y	7.13
ROCE	11.45
ROE	16.55
Roe5y	12.16
ROIC	23.53
Roic5y	15.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	22.24%
Cagr15y	21.54%
Cagr1y	33.52%
Cagr3y	17.94%
Cagr5y	17.33%
Div CAGR10	18.14%
Div CAGR3	19.3%
Div CAGR5	17.03%
EPS Growth	38.1
EPS Growth Q	41.67
EPS Growth Quarters	12
EPS Growth Years	3
EPS Growth3 Y	42.99
EPS Growth5 Y	18.59
FCF Growth	92.43%
FCF Growth Q	60.79%
FCF Growth3 Y	63.44%
FCF Growth5 Y	16.73%
OCF Growth	81.54%
OCF Growth Q	66.98%
OCF Growth10 Y	20.71%
OCF Growth3 Y	56.11%
OCF Growth5 Y	17.08%
Revenue Growth	13.27x
Revenue Growth Q	11.16x
Revenue Growth Quarters	23x
Revenue Growth Years	13x
Revenue Growth3 Y	14.85x
Revenue Growth5 Y	13.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.43
Assets	$629.5M
Cash	$367.2M
Current Assets	$477.8M
Current Liabilities	$33.4M
Debt	$189.8M
Debt EBITDA	$2.28
Debt Equity	$0.47
Debt FCF	$2.4
Equity	$406.6M
Interest Coverage	13.14
Liabilities	$222.9M
Long Term Assets	$151.7M
Long Term Liabilities	$189.5M
Net Cash	$177.4M
Net Cash By Market Cap	$7.19
Net Cash Growth	51.4%
Net Debt EBITDA	$-2.25
Net Debt Equity	$-0.44
Net Debt FCF	$-2.24
Tangible Book Value	$309M
Tangible Book Value Per Share	$13.52
WACC	7.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.32
Inventory Turnover	1.07
Net Working Capital	$80.7M
Quick ratio	12.08
Working Capital	$444.5M
Working Capital Turnover	$0.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.44%
Dividend Growth	25%
Dividend Growth Years	15%
Dividend per share	$1
Dividend Years	16
Dividend Yield	0.93%
Ex Div Date	2026-05-21
Last Dividend	$0.25
Payout Frequency	Quarterly
Payout Ratio	33.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	644.86%
1Y total return	33.49%
200-day SMA	93.67
3Y total return	64.07%
50-day SMA	110.4
50-day SMA vs 200-day SMA	50over200
5Y total return	122.32%
All Time High	118
All Time High Change	-8.53%
All Time High Date	2026-04-14
All Time Low	1.54
All Time Low Change	6,909.09%
All Time Low Date	2009-02-19
ATR	4.41
Beta	0.6
Beta1y	0.64
Beta2y	0.67
Ch YTD	33.1
High	109.7
High52	118
High52 Date	2026-04-14
High52ch	-8.53%
Low	105.3
Low52	78.35
Low52 Date	2025-05-23
Low52ch	37.77%
Ma50ch	-2.19%
Price vs 200-day SMA	15.23%
RSI	43.76
RSI Monthly	64.02
RSI Weekly	61.86
Sharpe ratio	0.86x
Sortino ratio	1.93
Total Return	0.49%
Tr YTD	33.4
Tr15y	1,765.04%
Tr1m	-2.17%
Tr1w	-3.66%
Tr3m	23.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Ratings	Buy
Earnings EPS Estimate	$0.66
Earnings EPS Estimate Growth	37.5
Earnings Revenue Estimate	66,670,480x
Earnings Revenue Estimate Growth	11.36x
Operating Income	$68.3M
Operating Income Growth	28.77
Operating Income Growth Q	40.78
Operating Income Growth3 Y	31.26
Operating Income Growth5 Y	16.43
Operating margin	26.64
Price target	$113
Price Target Change	$4.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	21,219,266%
Float Percent	92.86%
Shares Insiders	7.1%
Shares Institutions	94.63%
Shares Out	22,850,739
Shares Qo Q	0.27%
Shares Yo Y	0.44%
Short Float	6.47%
Short Ratio	5.41
Short Shares	6.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$71.3M
Average Volume	197,575.85x
Bv Per Share	17.8
CAPEX	$-8.2M
Ch10y	576.7
Ch15y	1,464.3
Ch1m	-2.17
Ch1w	-3.66
Ch1y	32.28
Ch3m	23.47
Ch3y	59.72
Ch5y	112.2
Ch6m	24.33
Change	0.03%
Change From Open	-0.06
Close	107.9
Days Gap	0.08
Depreciation Amortization	10,489,000
Dollar Volume	25,528,349.7
Earnings Date	2026-05-05
Earnings Time	amc
EBIT	$68.3M
EBITDA	$78.8M
EPS	$2.72
F Score	5
FCF	$79.1M
FCF EV Yield	3.46x
FCF Per Share	$3.46
Financing CF	-12,520,000
Fiscal Year End	December
Founded	1,983
Goodwill	65,945,000
Graham Number	33.00112
Graham Upside	-69.43
Income Tax	$18.2M
Investing CF	-73,742,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Lynch Fair Value	$57.34
Lynch Upside	-46.87
Ma150	94.48
Ma150ch	14.25%
Ma20	112.3
Ma20ch	-3.84%
Net CF	1,511,000
Next Earnings Date	2026-08-04
Open	108
Optionable	Yes
P FCF Ratio	31.17
P OCF Ratio	28.25
Payment Date	2026-06-04
Position In Range	59.96
Post Close	107.9
Postmarket Change Percent	0.11
Postmarket Price	$108
Ppne	48,375,000
Price Date	2026-05-08
Price EBITDA	$31.32
Ptbv Ratio	7.98
Relative Volume	1.2x
Revenue	256,282,000x
SBC By Revenue	3.07x
Share Based Comp	7,872,000
Tax By Revenue	7.11x
Tax Rate	22.59%
Tr6m	24.9%
Us State	Massachusetts
Volume	236,505
Z Score	7.44

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LMAT dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.9%

$1.00 annual per share

Payout ratio

+33.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+17.0%

15 consecutive years of growth

Total shareholder yield

+0.5%

Next ex-dividend date: 2026-05-21

Performance

LMAT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LMAT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+94.6%

Float: +92.9% of shares outstanding

Insider ownership

+7.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LMAT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.8

Neutral momentum band

Price vs 200-day MA

+15.2%

50/200-day relationship not available

Beta (5Y)

0.60

Less volatile than the market

Sharpe ratio

0.86

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LMAT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current LMAT stock rating?

LeMaitre Vascular, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full LMAT analysis?

The full report lives at /stocks/LMAT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for LMAT?

The latest report frames LMAT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the LMAT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.